How to Improve the Management of Acute Ischemic Stroke by Modern Technologies, Artificial Intelligence, and New Treatment Methods
- PMID: 34072071
- PMCID: PMC8229281
- DOI: 10.3390/life11060488
How to Improve the Management of Acute Ischemic Stroke by Modern Technologies, Artificial Intelligence, and New Treatment Methods
Abstract
Stroke remains one of the leading causes of death and disability in Europe. The European Stroke Action Plan (ESAP) defines four main targets for the years 2018 to 2030. The COVID-19 pandemic forced the use of innovative technologies and created pressure to improve internet networks. Moreover, 5G internet network will be helpful for the transfer and collecting of extremely big databases. Nowadays, the speed of internet connection is a limiting factor for robotic systems, which can be controlled and commanded potentially from various places in the world. Innovative technologies can be implemented for acute stroke patient management soon. Artificial intelligence (AI) and robotics are used increasingly often without the exception of medicine. Their implementation can be achieved in every level of stroke care. In this article, all steps of stroke health care processes are discussed in terms of how to improve them (including prehospital diagnosis, consultation, transfer of the patient, diagnosis, techniques of the treatment as well as rehabilitation and usage of AI). New ethical problems have also been discovered. Everything must be aligned to the concept of "time is brain".
Keywords: artificial intelligence; diagnosis; ischemia; ischemic stroke; management; plan; rehabilitation; robotics; stroke; treatment.
Conflict of interest statement
J.F.: Research support: BMBF, BMWi, DFG, EU, Acandis, Medtronic, Microvention, Stryker. Executive functions: University Medical Center Hamburg-Eppendorf, Eppdata GmbH. Stock: Tegus. Consultancy: Acandis, Codman, Cerenovus, Medtronic, Microvention, Penumbra, Route 92, Stryker, Transverse Medical; D.B. (Daniel Behme): None regarding the content of the article, consultant for Phenox, Balt, Vesalio and Acandis; I.V.: Speakers honoraria: Medtronic; K.Z., A.K., L.M., D.B.(Deniz Bulja), J.C., A.A.C., V.D.R., J.-C.G., J.H., O.K.-H., Ö.K., J.L., and E.P. declare no conflict of interest. The funders had no role in the writing of the manuscript.
Figures
References
-
- Benjamin: E.J., Virani S.S., Callaway C.W., Chamberlain A.M., Chang A.R., Cheng S., Chiuve S.E., Cushman M., Delling F.N., Deo R., et al. Heart disease and stroke statistics-2018 update: A report from the american heart association [published correction appears in circulation. Circulation. 2018;137:e67–e492. doi: 10.1161/CIR.0000000000000558. - DOI - PubMed
-
- Feigin V.L., Forouzanfar M.H., Krishnamurthi R., Mensah G.A., Connor M., Bennett D.A., Moran A.E., Sacco R.L., Anderson L., Truelsen T., et al. Global and regional burden of stroke during 1990-2010: Findings from the Global Burden of Disease Study 2010. Lancet. 2014;383:245–254. doi: 10.1016/S0140-6736(13)61953-4. - DOI - PMC - PubMed
-
- Mozaffarian D., Benjamin E.J., Go A.S., Arnett D.K., Blaha M.J., Cushman M., Das S.R., De Ferranti S., Després J.-P., Fullerton H.J., et al. Heart disease and stroke statistics-2016 update: A report from the american heart association. Circulation. 2016;133:e38–e360. doi: 10.1161/CIR.0000000000000350. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
